Trial Equity/Miller Tanner Partnership for Diversity
A Bold Step Forward: Trial Equity and Miller Tanner Associates Partner to Champion Diversity in Clinical Research
May 22, 2024 10:23 ET | Trial Equity
Trial Equity and Miller Tanner Associates are partnering to expand clinical trial participation to address the gap in diversity.
RAMM logo.jpg
RAMM Pharma Corp. Provides Update on Litigation
May 21, 2024 17:01 ET | RAMM Pharma Corp.
Not for Dissemination in the US or through US Newswire Services TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE:...
Y-Prime, LLC
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
May 21, 2024 08:00 ET | Y-Prime, LLC
YPrime's new glucometer/eCOA functionality offers a patient-centric, intuitive, and connected experience to clinical trial participants.
July 30, 2021 - ROSEN LOGO.jpg
ALT INVESTOR NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALT
May 09, 2024 14:52 ET | The Rosen Law Firm PA
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of...
AB Science:
AB Science:
May 07, 2024 12:05 ET | AB Science
COMMUNIQUE DE PRESSE UNE NOUVELLE PUBLICATION DANS LA REVUE MÉDICALE MUSCLE & NERVE VALIDE L’UTILISATION DU DECLIN DU SCORE ALSFRS-R (ΔFS) POUR LE DESIGN DES ETUDES CLINIQUES ET LE CHOIX DE...
AB Science : A new p
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient
May 07, 2024 12:05 ET | AB Science
PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN OF CLINICAL STUDIES AND THE TREATMENT CHOICE...
Jeff Cook Real Estate LPT Realty Named A Winner of the South Carolina Top Workplaces 2024 Award for Sixth Consecutive Year
Jeff Cook Real Estate LPT Realty Named A Winner of the South Carolina Top Workplaces 2024 Award for Sixth Consecutive Year
May 03, 2024 17:19 ET | Jeff Cook Real Estate
Columbia, SC, May 03, 2024 (GLOBE NEWSWIRE) -- The South Carolina Top Workplaces have awarded Jeff Cook Real Estate LPT Realty a Top Workplaces 2024 honor for the 6th consecutive year. This list is...
Updated Logo 2023 (3).png
Launch with Legal Soft: Free 2024 Grad Kickstart Program Powered by Practice 360!
May 02, 2024 14:49 ET | Legal Soft
LOS ANGELES, May 02, 2024 (GLOBE NEWSWIRE) -- Legal Soft, a leader in legal technology and innovative business solutions, in collaboration with Practice 360, is excited to announce a new,...
YPrime CNS Survey - Key eCOA Attributes
New YPrime Report Highlights eCOA's Impact on CNS Trials
May 01, 2024 08:00 ET | Y-Prime, LLC
YPrime has released a new report, Insights into CNS Clinical Trials, which demonstrates to sponsors how eCOA can help streamline CNS research.
Full Logo - OKYO .jpg
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
April 30, 2024 07:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...